Yong-Jian Geng

The University of Texas Health Science Center at Houston — United States

Medicine · Health Sciences

25h-index3.1kcitations41works2.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Mesenchymal stem cell research(5), Cardiomyopathy and Myosin Studies(4), Cardiac Ischemia and Reperfusion(4), Tissue Engineering and Regenerative Medicine(4), Atherosclerosis and Cardiovascular Diseases(4)

Publications41 total

Delivery of Superoxide Dismutase 3 Gene with Baculoviruses Inhibits TNF-α Triggers Vascular Smooth Muscle Cell Proliferation and Inflammation
Current Gene Therapy·2024· 2 cited
The influence of pre-existing hypertension on coronavirus disease 2019 patients
Epidemiology and Infection·2021· 24 citedOpen Access
Guidelines for the design and conduct of human clinical trials on ingestion-time differences – chronopharmacology and chronotherapy – of hypertension medications
Chronobiology International·2020· 37 citedOpen Access
Epigenetic regulation of insulin-like growth factor signaling: A novel insight into the pathophysiology of neonatal pulmonary hypertension
Vascular Pharmacology·2015· 12 cited
Cardioprotection by gene therapy
International Journal of Cardiology·2015· 32 citedOpen Access
CD1d serves as a surface receptor for oxidized cholesterol induction of peroxisome proliferator-activated receptor-γ
Atherosclerosis·2015· 7 cited
High glucose-induced hyperosmolarity impacts proliferation, cytoskeleton remodeling and migration of human induced pluripotent stem cells via aquaporin-1
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease·2014· 37 cited
Co-Activation of Nuclear Factor-κB and Myocardin/Serum Response Factor Conveys the Hypertrophy Signal of High Insulin Levels in Cardiac Myoblasts
Journal of Biological Chemistry·2014· 24 citedOpen Access
Simvastatin-enhanced expression of promyogenic nuclear factors and cardiomyogenesis of murine embryonic stem cells
Vascular Pharmacology·2013· 6 cited
Reprogramming somatic cells to pluripotency: A fresh look at Yamanaka’s model
Cell Cycle·2013· 11 citedOpen Access
Atorvastatin Enhance Efficacy of Mesenchymal Stem Cells Treatment for Swine Myocardial Infarction via Activation of Nitric Oxide Synthase
PLoS ONE·2013· 109 citedOpen Access
Myocardin-A enhances expression of promyogenic genes without depressing telomerase activity in adipose tissue-derived mesenchymal stem cells
International Journal of Cardiology·2012· 16 cited
Phosphorylation of endothelial NOS contributes to simvastatin protection against myocardial no-reflow and infarction in reperfused swine hearts: partially via the PKA signaling pathway
Acta Pharmacologica Sinica·2012· 28 citedOpen Access
Linking immunity to atherosclerosis: Implications for vascular pharmacology — A tribute to Göran K. Hansson
Vascular Pharmacology·2011· 10 citedOpen Access
High levels of glucose induce apoptosis in cardiomyocyte via epigenetic regulation of the insulin-like growth factor receptor
Experimental Cell Research·2010· 54 cited
Angiotensin Receptor Agonistic Autoantibody–Mediated Tumor Necrosis Factor-α Induction Contributes to Increased Soluble Endoglin Production in Preeclampsia
Circulation·2010· 82 citedOpen Access
Liposomal modular complexes for simultaneous targeted delivery of bioactive gases and therapeutics
Journal of Controlled Release·2009· 27 citedOpen Access
Delivery of Stem Cells to Porcine Arterial Wall with Echogenic Liposomes Conjugated to Antibodies against CD34 and Intercellular Adhesion Molecule-1
Molecular Pharmaceutics·2009· 50 citedOpen Access
Erythropoietin protects myocardin-expressing cardiac stem cells against cytotoxicity of tumor necrosis factor-α
Experimental Cell Research·2009· 16 cited
Insulin-like growth factor-1 receptor activation prevents high glucose-induced mitochondrial dysfunction, cytochrome-c release and apoptosis
Biochemical and Biophysical Research Communications·2009· 49 cited
page 1 of 3Next →

Frequent Co-authors

Rosalinda Madonna(8), Raffaele De Caterina(7), James T. Willerson(6), Harnath Shelat(6), Yangxin Li(5), Stephen F. Vatner(4), Emerson C. Perin(3), L. Maximilian Buja(3), Yoshihiro Ishikawa(3), Sanford P. Bishop(3), Yue-Jin Yang(3), Michael Wassler(3), Rumin He(2), Dong-Chuan Guo(2), Anthony L. Estrera(2), Hazim J. Safi(2), Dianna M. Milewicz(2), Dorothy E. Vatner(2), Thomas E. Wagner(2), C J Homcy(2)